(Q40450424)

20 September 2017

Interferon-beta-induced activation of c-Jun NH2-terminal kinase mediates apoptosis through up-regulation of CD95 in CH31 B lymphoma cells. (English)

1 reference

20 September 2017

Eiko Takada

1

1 reference

20 September 2017

Kuniaki Shimo

2

1 reference

20 September 2017

Kikumi Hata

3

1 reference

20 September 2017

Maira Abiake

4

1 reference

20 September 2017

Yasuo Mukai

5

1 reference

20 September 2017

Masami Moriyama

6

1 reference

20 September 2017

Lynn Heasley

7

1 reference

20 September 2017

Junichiro Mizuguchi

8

1 reference

20 September 2017

language of work or name

English

0 references

publication date

19 December 2004

1 reference

Experimental Cell Research

20 September 2017

1 reference

20 September 2017

304

1 reference

20 September 2017

2

1 reference

20 September 2017

518-530

1 reference

Activation of the Jak-Stat Pathway in Cells That Exhibit Selective Sensitivity to the Antiviral Effects of IFN-beta Compared with IFN-alpha

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Cytokine therapeutics: lessons from interferon alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Interferon versus ribavirin plus interferon in chronic hepatitis C previously resistant to interferon: a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Close link between reduction of c-myc expression by interferon and, G0/G1 arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Interferon-alpha enhances CD95L-induced apoptosis of human malignant glioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Involvement of TRAIL/TRAIL-R interaction in IFN-alpha-induced apoptosis of Daudi B lymphoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Fas receptor-mediated apoptosis: a clinical application?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Fas ligand-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

The Fas signaling pathway: more than a paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Two CD95 (APO-1/Fas) signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Mitochondria as regulators of apoptosis: doubt no more.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

The role of c-FLIP in modulation of CD95-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Regulation of lymphocyte proliferation and death by FLIP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Inhibition of death receptor signals by cellular FLIP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

The type-I interferon receptor. The long and short of it.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Signaling by type I and II cytokine receptors: ten years after

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

A weak signal for strong responses: interferon-alpha/beta revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Mammalian MAP kinase signalling cascades

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Signal transduction by the JNK group of MAP kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Resident bone marrow macrophages produce type 1 interferons that can selectively inhibit interleukin-7-driven growth of B lineage cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Role of T cell-derived lymphokines in two models of B-cell tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

The CH series of murine B cell lymphomas: neoplastic analogues of Ly-1+ normal B cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Effects of interferon alpha on autocrine growth factor loops in B lymphoproliferative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Interferon-beta induced remission in a hairy cell leukemia patient resistant to interferon-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Prevention of anti-IgM-induced apoptosis accompanying G1 arrest in B lymphoma cells overexpressing dominant-negative mutant form of c-Jun N-terminal kinase 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Requirement of c-Jun N terminal kinase and P38 mitogen-activated protein kinase for anti-IgM-induced reduction in mitochondrial membrane potential in CH31 B lymphoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Bcl-x(L) confers multi-drug resistance in several squamous cell carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Differential gene regulation by specific gain-of-function JNK1 proteins expressed in Swiss 3T3 fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

The role of FAS-mediated apoptosis in chronic myelogenous leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Activation-induced cell death in B lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Distinct molecular mechanisms of Fas resistance in murine B lymphoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Regulation of fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Hyperosmolarity and CD95L trigger CD95/EGF receptor association and tyrosine phosphorylation of CD95 as prerequisites for CD95 membrane trafficking and DISC formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Mechanisms of Interferon-alpha induced apoptosis in malignant cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

Cytochrome c release, mitochondrial membrane depolarization, caspase-3 activation, and Bax-alpha cleavage during IFN-alpha-induced apoptosis in Daudi B lymphoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.11.015

10.1016/J.YEXCR.2004.11.015

7 January 2021

Identifiers

DOI

1 reference

release_teynkiiybvcaxkfzcltqctnnb4

20 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/teynkiiybvcaxkfzcltqctnnb4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference